We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Port Erin | LSE:PEBI | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.50 | 4.00 | 5.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPEBI
RNS Number : 4991S
Port Erin Biopharma Investments Ltd
18 March 2016
18 March 2016
Port Erin Biopharma Investments Limited
(the "Company")
The Company has been informed today that the 2,715,614 Ordinary Shares held by Shellbay Investments Limited have been transferred to Galloway Limited. As a result, Galloway Limited is now interested in 5,455,313 Ordinary Shares, representing 23.5% of Company's issued capital.
Both Shellbay Investments Limited and Galloway Limited are indirectly owned by Jim Mellon, the Company's Chairman.
For further information, please contact:
Port Erin Biopharma Beaumont Cornish Peterhouse Capital Investments Limited Limited Limited -------------------- ---------------- --------------------- The Company Nomad Broker -------------------- ---------------- --------------------- Denham Eke Roland Cornish/ Lucy Williams +44 (0) 1624 639396 James Biddle +44 (0) 207 469 0936 +44 (0) 207 628 3396 -------------------- ---------------- ---------------------
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLJRMPTMBMBBPF
(END) Dow Jones Newswires
March 18, 2016 03:00 ET (07:00 GMT)
1 Year Port Erin Chart |
1 Month Port Erin Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions